To address the current challenges faced by cross-border participants in clinical trials, the EU-X-CT initiative has developed general recommendations on key aspects of clinical trial management and conduct. The recommendations aim to improve safe and equitable access to cross-border clinical trials within Europe.
This document was developed in consultation with over 100 members from 32 countries. Currently in the draft stage, the recommendations will be finalized following a public consultation to ensure all stakeholder perspectives are considered.
Borders Should No Longer Be Barriers In Clinical Trials.
The draft recommendations are now open for public consultation. We need your feedback to ensure these recommendations work for all stakeholders involved in cross-border clinical trials.
Duration: 5 Weeks, from 03 February 2025 to 10 March 2025, 12.00 PM CET
How to Provide Feedback
We look forward to receiving your valuable feedback.